Skip to content
Fundamentalis
Fundamentalis
Insightful market commentary from a fresh perspective.
  • Home
  • About Brian
  • Trinity Asset Management

Category: Gilead

10.5.14: More on SP 500 Earnings and a Look at Revenue Estimates by Sector

October 5, 2014 Brian Gilmartin Leave a comment

Our primary source of earnings data is Thomson Reuters, both the weekly “This Week in Earnings” and the intermittent emails,…

Continue Reading →

Posted in: Biotech, Financial sector, Financials, Gilead, MSFT, S&P 500, SP 500 Revenue Growth

5.10.14: SP 500 Earnings Update: Q1 ’14 Earnings +5.4%, i.e. Stronger Than Expected

May 10, 2014 Brian Gilmartin Leave a comment

Per Thomson Reuter’s, “This Week in Earnings”, the forward 4-quarter estimate this week, slipped a little from last weeks $123.19…

Continue Reading →

Posted in: Apple (AAPL), Earnings, Earnings estimate revisions, Fed Model, Gilead, Sector Earnings Growth Estimates, Weekly Earnings Update

5.6.14: Healthcare Earnings Deep-Dive

May 6, 2014 Brian Gilmartin Leave a comment

Last weekend, in our Weekly Earnings Update here, we noted the strength in SP 500 earnings was coming from Technology…

Continue Reading →

Posted in: Biotech sector / earnings, Facebook (FB), Gilead

Fundamentalis

  • Schwab Earnings Preview: Cheap on a PEG Basis, Can Schwab Break-out of this 3-year Consolidation?
  • Netflix Earnings Preview: Margin Guidance Continues to be Revised Higher
  • Financials Report This Week: Citi and JPMorgan Kick-Off the Big Banks Tuesday Morning
  • Technology Sector: Looking at the Last 5 Quarters “Upside Surprise” Factor
  • SP 500 Earnings: Nothing Much This Week, but Don’t Ignore Non-Correlated

Subscribe to Fundamentalis

Loading

Archives

Copyright © 2025 Fundamentalis